TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Nordic Biomarker AB
Closing information (x1000 NOK)
Closing information | 2022/12 | 2021/12 (consolidated) | 2020/12 (consolidated) |
Turnover | 122,616 | 127,502 | 114,132 |
Financial expenses | 1,706 | 381 | 416 |
Earnings before taxes | -23,942 | -10 | 13,923 |
EBITDA | -13,672 | 11,699 | 23,646 |
Total assets | 196,843 | 169,523 | 165,987 |
Current assets | 67,173 | 71,387 | 76,504 |
Current liabilities | 67,309 | 35,925 | 30,370 |
Equity capital | 127,975 | 96,748 | 107,074 |
- share capital | 142 | 146 | 157 |
Employees (average) | 75 | 66 | 56 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 (consolidated) | 2020/12 (consolidated) |
Solvency | 65.0% | 57.1% | 64.5% |
Turnover per employee | 1,635 | 1,932 | 2,038 |
Profit as a percentage of turnover | -19.5% | 0.0% | 12.2% |
Return on assets (ROA) | -11.3% | 0.2% | 8.6% |
Current ratio | 99.8% | 198.7% | 251.9% |
Return on equity (ROE) | -18.7% | 0.0% | 13.0% |
Change turnover | |||
Change turnover % | 20% | ||
Chg. No. of employees | |||
Chg. No. of employees % | 18% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 (consolidated) | 2020/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.